HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.

Multiple Sclerosis

The NeurologyLive® multiple sclerosis (MS) clinical focus page offers information, podcasts, videos, and news about the latest study and clinical trial findings, FDA actions, clinical guideline updates, and expert interviews related to the care and management of patients with MS, including relapsing MS and progressive MS, as well as related disorders such as neuromyelitis optica spectrum disorder.

Check out some of NeurologyLive®'s featured content in the carousel below.

Treating NMOSD Early in the Disease Course: Inebilizumab’s Efficacy in N-MOmentum

November 26, 2022

Article

Bruce Cree, MD, PhD, MAS, FAAN, offered his perspective on data from the phase 2/3 N-MOmentum trial of the recently approved inebilizumab (Uplizna; Horizon Therapeutics) and why the therapy stands out from other NMOSD treatments.

Aquatic Therapy Improves MS Fatigue, MS Disease Pathology Not Defined by Courses, Rituximab Shows Positive Effect in Myasthenia Gravis

November 26, 2022

Video

Neurology News Network for the week ending November 26, 2022. [WATCH TIME: 4 minutes]

NeurologyLive® Friday 5 — November 25, 2022

November 25, 2022

Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 25, 2022.

CBT as an Effective Mood Therapy for Patients with MS Experiencing Fatigue: Federica Picariello, PhD

November 25, 2022

Video

The postdoctoral researcher and health psychologist at King's College, London spoke at ECTRIMS 2022 about the relationship between mood and fatigue in patients with MS. [WATCH TIME: 2 minutes]

Cognition Issues in Multiple Sclerosis Are Vital to Address

November 25, 2022

Article

Cognitive problems have been reported to occur in as many as 7 in 10 individuals with MS, yet they remain a difficult and undertreated challenge in clinical care.

Furthering MS Treatment Selection: A Comparative Study of Peginterferon Beta-1a vs Interferon Beta-1a

November 24, 2022

Article

Peginterferon beta-1a, a pegylated form of interferon designed to maintain biologic effects in the body for longer periods, is being evaluated against CinnaGen’s interferon beta-1a formulation, CinnoVex.

The Relationship Between Epstein-Barr Virus and Multiple Sclerosis

November 23, 2022

Article

The paradigm-shifting evidence of the link between MS and EBV does not exist in isolation. In fact, the relationship has been suspected for more than 40 years, and evidence therein has been accumulating over the past 2 decades.

Future Thoughts on Improving MS Trial Design, Calculations: Carrie Hersh, DO, MSc

November 23, 2022

Video

The associate professor of neurology at the Cleveland Clinic Lerner College of Medicine provided perspective on how the clinical community can improve trials for multiple sclerosis that help improve treatment decisions. [WATCH TIME: 4 minutes]

Physical Movement Improves Fatigue for Patients with MS: Federica Picariello, PhD

November 22, 2022

Video

The postdoctoral researcher and health psychologist at King's College, London spoke at ECTRIMS 2022 about the most important aspect for improving fatigue in MS. [WATCH TIME: 4 minutes]

Aquatic Therapy May Positively Impact Fatigue, Balance in Multiple Sclerosis

November 22, 2022

Article

Compared with conventional treatments, which included routine pharmaceutical treatments or occupational therapy without exercise, aquatic therapy showed several benefits in physical, cognitive, and psychosocial fatigue for patients with MS.